135 related articles for article (PubMed ID: 14582847)
1. Design and synthesis of phosphonoacetic acid (PPA) ester and amide bioisosters of ribofuranosylnucleoside diphosphates as potential ribonucleotide reductase inhibitors and evaluation of their enzyme inhibitory, cytostatic and antiviral activity.
Manfredini S; Solaroli N; Angusti A; Nalin F; Durini E; Vertuani S; Pricl S; Ferrone M; Spadari S; Focher F; Verri A; De Clercq E; Balzarini J
Antivir Chem Chemother; 2003 Jul; 14(4):183-94. PubMed ID: 14582847
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, cytostatic activity and inhibition of ribonucleotide reductase by 5'-phosphoramidates and 5'-diphosphates, of 2'-O-allyl-arabinofuranosyl nucleosides.
Manfredini S; Baraldi PG; Durini E; Balzarini J; De Clercq E; Karlsson A; Buzzoni V; Thelander L
Nucleosides Nucleotides; 1999; 18(4-5):1007-8. PubMed ID: 10432732
[TBL] [Abstract][Full Text] [Related]
3. 5'-Phosphoramidates and 5'-diphosphates of 2'-O-allyl-beta-D-arabinofuranosyluracil, -cytosine, and -adenine: inhibition of ribonucleotide reductase.
Manfredini S; Baraldi PG; Durini E; Vertuani S; Balzarini J; De Clercq E; Karlsson A; Buzzoni V; Thelander L
J Med Chem; 1999 Aug; 42(17):3243-50. PubMed ID: 10464011
[TBL] [Abstract][Full Text] [Related]
4. Ribonucleotide reductase: a mechanistic portrait of substrate analogues inhibitors.
Perez MA; Cerqueira NM; Fernandes PA; Ramos MJ
Curr Med Chem; 2010; 17(26):2854-72. PubMed ID: 20858168
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological activity of a bivalent nucleotide inhibitor of ribonucleotide reductase.
Wu X; Cooperman BS
Bioorg Med Chem Lett; 2000 Oct; 10(20):2387-9. PubMed ID: 11055362
[TBL] [Abstract][Full Text] [Related]
6. Selection and characterization of mutant S49 T-lymphoma cell lines resistant to phosphonoformic acid: evidence for inhibition of ribonucleotide reductase.
Albert DA; Gudas LJ
J Cell Physiol; 1986 May; 127(2):281-7. PubMed ID: 2939095
[TBL] [Abstract][Full Text] [Related]
7. Sugar-modified conjugated diene analogues of adenosine and uridine: synthesis, interaction with S-adenosyl-L-homocysteine hydrolase, and antiviral and cytostatic effects.
Wnuk SF; Ro BO; Valdez CA; Lewandowska E; Valdez NX; Sacasa PR; Yin D; Zhang J; Borchardt RT; De Clercq E
J Med Chem; 2002 Jun; 45(12):2651-8. PubMed ID: 12036374
[TBL] [Abstract][Full Text] [Related]
8. Adenosine phosphonoacetic acid is slowly metabolized by NDP kinase.
Chen Y; Morera S; Pasti C; Angusti A; Solaroli N; Véron M; Janin J; Manfredini S; Deville-Bonne D
Med Chem; 2005 Nov; 1(6):529-36. PubMed ID: 16787337
[TBL] [Abstract][Full Text] [Related]
9. Theoretical study on the inhibition of ribonucleotide reductase by 2'-mercapto-2'-deoxyribonucleoside-5'-diphosphates.
Pereira S; Fernandes PA; Ramos MJ
J Am Chem Soc; 2005 Apr; 127(14):5174-9. PubMed ID: 15810852
[TBL] [Abstract][Full Text] [Related]
10. A potent peptidomimetic inhibitor of HSV ribonucleotide reductase with antiviral activity in vivo.
Liuzzi M; Déziel R; Moss N; Beaulieu P; Bonneau AM; Bousquet C; Chafouleas JG; Garneau M; Jaramillo J; Krogsrud RL
Nature; 1994 Dec; 372(6507):695-8. PubMed ID: 7990963
[TBL] [Abstract][Full Text] [Related]
11. Synergistic antiviral action of ribonucleotide reductase inhibitors and 3'-azido-3'-deoxythymidine on HIV type 1 infection in vitro.
Giacca M; Borella S; Calderazzo F; Bianchi LC; D'Agaro P; Rampazzo C; Bianchi V; Reichard P
AIDS Res Hum Retroviruses; 1996 May; 12(8):677-82. PubMed ID: 8744578
[TBL] [Abstract][Full Text] [Related]
12. The effect of phosphonoformic acid on wild type and mutant S49 cell lines.
Albert DA; Gudas LJ
Adv Exp Med Biol; 1986; 195 Pt B():185-9. PubMed ID: 2945406
[No Abstract] [Full Text] [Related]
13. Overview of ribonucleotide reductase inhibitors: an appealing target in anti-tumour therapy.
Cerqueira NM; Pereira S; Fernandes PA; Ramos MJ
Curr Med Chem; 2005; 12(11):1283-94. PubMed ID: 15974997
[TBL] [Abstract][Full Text] [Related]
14. From the covalent linkage of drugs to novel inhibitors of ribonucleotide reductase: synthesis and biological evaluation of valproic esters of 3'-C-methyladenosine.
Petrelli R; Meli M; Vita P; Torquati I; Ferro A; Vodnala M; D'Alessandro N; Tolomeo M; Del Bello F; Kusumanchi P; Franchetti P; Grifantini M; Jayaram HN; Hofer A; Cappellacci L
Bioorg Med Chem Lett; 2014 Nov; 24(22):5304-9. PubMed ID: 25304896
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and evaluation of octahydropyranopyrrole-based inhibitors of mammalian ribonucleotide reductase.
Fuertes MJ; Kaur J; Deb P; Cooperman BS; Smith AB
Bioorg Med Chem Lett; 2005 Dec; 15(23):5146-9. PubMed ID: 16176875
[TBL] [Abstract][Full Text] [Related]
16. Asymmetric synthesis and antiviral activities of L-carbocyclic 2', 3'-didehydro-2',3'-dideoxy and 2',3'-dideoxy nucleosides.
Wang P; Gullen B; Newton MG; Cheng YC; Schinazi RF; Chu CK
J Med Chem; 1999 Aug; 42(17):3390-9. PubMed ID: 10464025
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antiviral evaluation of cis-substituted cyclohexenyl and cyclohexanyl nucleosides.
Barral K; Courcambeck J; Pèpe G; Balzarini J; Neyts J; De Clercq E; Camplo M
J Med Chem; 2005 Jan; 48(2):450-6. PubMed ID: 15658858
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and evaluation of peptide inhibitors of Mycobacterium tuberculosis ribonucleotide reductase.
Nurbo J; Roos AK; Muthas D; Wahlström E; Ericsson DJ; Lundstedt T; Unge T; Karlén A
J Pept Sci; 2007 Dec; 13(12):822-32. PubMed ID: 17918768
[TBL] [Abstract][Full Text] [Related]
19. Understanding the molecular mechanism of viral resistance to peptidomimetic inhibitors of ribonucleotide reductase.
White PW
Biochim Biophys Acta; 1998 Jan; 1382(1):102-10. PubMed ID: 9507079
[TBL] [Abstract][Full Text] [Related]
20. A solid-phase assay for the binding of peptidic subunit association inhibitors to the herpes simplex virus ribonucleotide reductase large subunit.
Krogsrud RL; Welchner E; Scouten E; Liuzzi M
Anal Biochem; 1993 Sep; 213(2):386-94. PubMed ID: 8238915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
